STEPHANIE HELMINIAK: Open Payments
NPI 1043785959 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,108 in 276 payments from 28 companies in 2025. Trend: 2023 $1,613 · 2024 $4,379 · 2025 $5,108
Food & beverage: $4,688Education: $420
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $649 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 29 | $634 |
| UCB, Inc. | 22 | $504 |
| Janssen Biotech, Inc. | 50 | $466 |
| Regeneron Healthcare Solutions, Inc. | 15 | $461 |
| Amgen Inc. | 17 | $447 |
| GENZYME CORPORATION | 12 | $331 |
| Novartis Pharmaceuticals Corporation | 12 | $269 |
| Galderma Laboratories, L.P. | 20 | $232 |
| Incyte Corporation | 7 | $146 |
Products named: DUPIXENT, Bimzelx, TREMFYA, SKYRIZI, ILUMYA, OTEZLA, RINVOQ, NEMLUVIO.
Industry payments across MI — which companies pay providers there.
